Can Ashwagandha Benefit the Endocrine System?-A Review.
Study Design
- 研究类型
- Review
- 干预措施
- Can Ashwagandha Benefit the Endocrine System?-A Review. None
- 对照组
- Placebo
- 效应方向
- Positive
- 偏倚风险
- Unclear
Abstract
Withania somnifera, also known as Ashwagandha, has been used in traditional medicine for thousands of years. Due to the wide range of its activities, there has been interest in its possible beneficial effects on the human body. It is proved that, among others, Ashwagandha has anti-stress, anti-inflammatory, antimicrobial, anti-cancer, anti-diabetic, anti-obesity, cardioprotective, and hypolipidemic properties. Particularly interesting are its properties reported in the field of psychiatry and neurology: in Alzheimer's disease, Parkinson's disease, multiple sclerosis, depression, bipolar disorder, insomnia, anxiety disorders and many others. The aim of this review is to find and summarize the effect that Ashwagandha root extract has on the endocrine system and hormones. The multitude of active substances and the wide hormonal problems faced by modern society sparked our interest in the topic of Ashwagandha's impact on this system. In this work, we also attempted to draw conclusions as to whether W. somnifera can help normalize the functions of the human endocrine system in the future. The search mainly included research published in the years 2010-2023. The results of the research show that Ashwagandha can have a positive effect on the functioning of the endocrine system, including improving the secretory function of the thyroid gland, normalizing adrenal activity, and multidirectional improvement on functioning of the reproductive system. The main mechanism of action in the latter appears to be based on the hypothalamus-pituitary-adrenal (HPA) axis, as a decrease in cortisol levels and an increase in hormones such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in men were found, which results in stress level reduction and improvement in fertility. In turn, other studies prove that active substances from W. somnifera, acting on the body, cause an increase in the secretion of triiodothyronine (T3) and thyroxine (T4) by the thyroid gland and a subsequent decrease in the level of thyroid-stimulating hormone (TSH) in accordance with the hypothalamus-pituitary-thyroid (HPT) axis. In light of these findings, it is clear that Ashwagandha holds significant promise as a natural remedy for various health concerns, especially those related to the endocrine system. Future research may provide new insights into its mechanisms of action and expand its applications in both traditional and modern medicine. The safety and toxicity of Ashwagandha also remain important issues, which may affect its potential use in specific patient groups.
Full Text
Figures
Figure 1
Overview of the multiple endocrine pathways potentially influenced by Ashwagandha (Withania somnifera), including thyroid, adrenal, and reproductive hormone axes.
diagram
Figure 2
Molecular mechanisms through which Ashwagandha's bioactive compounds, particularly withanolides, may modulate endocrine function and hormone signaling.
diagram
Figure 3
Summary of clinical and preclinical evidence for Ashwagandha's effects on specific endocrine parameters, including cortisol, thyroid hormones, and testosterone levels.
diagramTables
Table 1
| Compounds | Part of | Active Substances |
|---|---|---|
| Alkaloids | Leaves, roots, stems | Ashwagandhine, anahygrine, |
| Flavonoids | Roots, stems | Quercetin, 7-hydroxyflavone |
| Glycosides | Roots, stems | Withanosides I–VII, |
| Phenolic | Roots, stems | Coumaric acid, caffeic acid, |
| Saponins | Roots, berries | Sitoindoside VII, sitoindoside VIII |
| Steroids | Roots | β-sitosterol, cholesterol, |
| Steroidal lactones | Leaves, roots | Withaferin–A, withanone, |
| Tannins | Roots, leaves, fruits, flowers | Not available |
Table 2
| Active Substance | Potential Effects | References |
|---|---|---|
| Anaferine | anti-tuberculous, | [ |
| neuroprotective | [ | |
| Anahygrine | anti-tuberculous, | [ |
| neuroprotective | [ | |
| Withaferin A | anti-inflammatory, | [ |
| anti-cancer, | [ | |
| anti-diabetic, | [ | |
| cardioprotective, | [ | |
| neuroprotective, | [ | |
| antibacterial, | [ | |
| anti-SARS-CoV-2, | [ | |
| in dermatological diseases | [ | |
| Withanolide D | neuroprotective, | [ |
| anti-cancer | [ | |
| Withanone | antibacterial, | [ |
| anti-SARS-CoV-2, | [ | |
| anti-cancer | [ |
Table 3
| Authors | Characteristic of the Group | Ashwagandha Formulation Characteristics | Duration of the Observation | Results | References |
|---|---|---|---|---|---|
| Lopresti et al. | stressed healthy males and females 18–64 years old, with a HAM-A between 6 and 17 | 240 mg of Ashwagandha extract per day for 15–days, standarized contain 35% withanolide glycosides—approximately 84 mg withanolide; | 60 days after commencement of 15-day capsule intake | ↓cortisol ↓DHEA-S | [ |
| Salve J et al. | 60 participants (males and females), divided into three groups | one study group receiving 250 mg of Ashwagandha root extract per day; another study group receiving 600 mg of Ashwaganda extract per day; | 8 weeks | ↓anxiety | [ |
| Mahdi et al. | 121 men, 25–38 years. | 5 mg of Ashwagandha root powder for three months; | The | ↑LH | [ |
| Priyanka G et al. | 24 healthy Kathiawari | high-concentration full-spectrum Ashwagandha root powder, containing ≥5% of withanolides; | 21 days of intake, after 14 days of intake horses were subjected to different kind of stress | ↓cortisol | [ |
Table 4
| Authors | Characteristic of the Group | Ashwagandha Formulation Characteristics | Duration of the Observation | Results | References |
|---|---|---|---|---|---|
| Baghel et al. | 18 sexually mature six weeks old male Japanese quail as a animal model of infertility, provoked by using photoperiodic chambers | 100 mg/day/kg of | few months of inducing infertility using photoperiodic chambers and 45 days of Ashwagandha administration | ↑expression of estrogen receptor alpha | [ |
| Megahd et al. | 50 adult female rats; | 200 mg/kg | 1 month | ↑FSH | [ |
| Ajgaonkar et al. | prospective, randomized, placebo-controlled study; 80 women, 18–50 years old, without any hormonal disturbances and having hypoactive sexual desire disorder (HSDD) with a Female Sexual Function Index (FSFI) score < 26, or Female Sexual Distress Scale (FSDS) score > 11 | 300 mg of standardized Ashwagandha root extract twice daily; | 8 weeks | -improvement in sexual functions | [ |
| Chauhan et al. | randomized, controlled trial; 50 healthy male subjects with low sexual desire | 300 mg of Ashwagandha root extract twice daily; | 8 weeks | ↑testosterone | [ |
Table 5
| Authors | Characteristic of the Group | Ashwagandha Formulation Characteristics | Duration of the Observation | Results | References |
|---|---|---|---|---|---|
| Sharma et al. | males and females, 18–50 years old, with subclinical hypothyroidism | 300 mg of Ashwagandha root extract twice a day; oral administration | 8 weeks of treatment | ↑ T3 | [ |
| Abdel-Wahhab et al. | male albino rats with induced hypothyroidism | 500 mg/kg/day of Ashwagandha methanolic extract; oral administraion | 30 days | ↑ T3 | [ |
| Ibrahim et al. | male Wistar albino rats with induced hypothyroidism | 50 mg/kg/day of Ashwagandha extract; oral administraion | 30 days | ↑ T3 | [ |
References
- Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects Biomed. Pharmacother., 2021
- Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review Pharmaceutics, 2023
- Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective Iran. J. Basic Med. Sci., 2020
- Withania somnifera (L.) Dunal—Modern perspectives of an ancient Rasayana from Ayurveda J. Ethnopharmacol., 2021
- Review of Plant Extracts and Active Components: Mechanisms of Action for the Treatment of Obesity-Induced Cognitive Impairment Brain Sci., 2023
- Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma Cancers, 2019
- Neuroprotective Herbs for the Management of Alzheimer’s Disease Biomolecules, 2021
- Neurodegenerative diseases and Withania somnifera (L.): An update J. Ethnopharmacol., 2020
- Adjunctive use of a standardized extract of withania somnifera (ashwagandha) to treat symptom exacerbation in schizophrenia: A randomized, double-blind, placebo-controlled study J. Clin. Psychiatry, 2018
- Heterosis Studies for Root-Yield-Attributing Characters and Total Alkaloid Content over Different Environments in Withania somnifera L. Agriculture, 2023
- Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy Front. Cell. Infect. Microbiol., 2022
- Role of Withania somnifera (Ashwagandha) in the management of male infertility Reprod. Biomed. Online, 2018
- Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial J. Altern. Complement. Med., 2018
- Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract for Improvement of Sexual Health in Healthy Women: A Prospective, Randomized, Placebo-Controlled Study Cureus, 2022
- Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery Microorganisms, 2023
- An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study Medicine, 2019
- Super Critical Fluid Extracted Fatty Acids from Withania somnifera Seeds Repair Psoriasis-Like Skin Lesions and Attenuate Pro-Inflammatory Cytokines (TNF-α and IL-6) Release Biomolecules, 2020
- Antitumor Potential of Withanolide Glycosides from Ashwagandha (Withania somnifera) on Apoptosis of Human Hepatocellular Carcinoma Cells and Tube Formation in Human Umbilical Vein Endothelial Cells Antioxidants, 2022
- Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study Curr. Res. Struct. Biol., 2021
- Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal J. Ethnopharmacol., 2021
- Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia Curr. Neuropharmacol., 2021
- Biodiversity, Biochemical Profiling, and Pharmaco-Commercial Applications of Withania somnifera: A Review Molecules, 2023
- Withania somnifera L.: Phenolic Compounds Composition and Biological Activity of Commercial Samples and Its Aqueous and Hydromethanolic Extracts Antioxidants, 2023
- Withaferin A: From Ancient Remedy to Potential Drug Candidate Molecules, 2021
- Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives Biomedicines, 2020
- Alkaloids in Withania somnifera (L.) Dunal Root Extract Contribute to Its Anti-Inflammatory Activity Pharmacology, 2023
- Exploring the potential and identifying Withania somnifera alkaloids as novel dihydrofolate reductase (DHFR) inhibitors by the AlteQ method J. Biomol. Struct. Dyn., 2023
- Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study Med. Hypotheses, 2016
- Network pharmacological evaluation of Withania somnifera bioactive phytochemicals for identifying novel potential inhibitors against neurodegenerative disorder J. Biomol. Struct. Dyn., 2022
- Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer’s and Parkinson’s diseases as druggable targets through Withania somnifera bioactives: An in silico study J. Biomol. Struct. Dyn., 2023
- Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin A BMC Genom., 2010
- Inhibition of VEGF: A novel mechanism to control angiogenesis by Withania somnifera’s key metabolite Withaferin A In Silico Pharmacol., 2013
- Ashwagandha in brain disorders: A review of recent developments J. Ethnopharmacol., 2020
- Synthesis, In-Vitro and In-Silico Evaluation of Silver Nanoparticles with Root Extract of Withania somnifera for Antibacterial Activity via Binding of Penicillin-Binding Protein-4 Curr. Pharm. Biotechnol., 2020
- The Natural Products Withaferin A and Withanone from the Medicinal Herb Withania somnifera Are Covalent Inhibitors of the SARS-CoV-2 Main Protease J. Nat. Prod., 2022
- Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells J. Biomol. Struct. Dyn., 2022
- Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases Molecules, 2021
- Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network Liver Int., 2020
- DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha) Curr. Res. Toxicol., 2021
- Withania somnifera aqueous extract facilitates the expression and release of GnRH: In vitro and in vivo study Neurochem. Int., 2015
- The methanolic extract of Withania somnifera ACTS on GABAA receptors in gonadotropin releasing hormone (GnRH) neurons in mice Phytother. Res., 2010
- Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study Cureus, 2019
- Withania somnifera Improves Semen Quality in Stress-Related Male Fertility Evid. Based Complement. Altern. Med., 2011
- Adaptogenic and Immunomodulatory Activity of Ashwagandha Root Extract: An Experimental Study in an Equine Model Front. Vet. Sci., 2020
- Promising prospective effects of Withania somnifera on broiler performance and carcass characteristics: A comprehensive review Front. Vet. Sci., 2022
- Botanicals in health and disease of the testis and male fertility: A scoping review Phytomedicine, 2022
- On Males, Antioxidants and Infertility (MOXI): Certitudes, Uncertainties and Trends Antioxidants, 2023
- Male Infertility. 3 March 2023 StatPearls, 2023
- Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: A randomized controlled trial Health Sci. Rep., 2022
- The most important medicinal plants affecting sperm and testosterone production: A systematic review JBRA Assist. Reprod., 2022
- Photoperiod dependent expression of estrogen receptor alpha in testes of Japanese quail: Involvement of Withania somnifera in apoptosis amelioration Biochem. Biophys. Res. Commun., 2021
- Evaluation of Matcha (Camellia sinensis) and Ashwagandha (Withania somnifera) Efficacy Against Utero-Ovarian Injury in Rats Pak. J. Biol. Sci., 2021
- Effects of Withania somnifera (Ashwagandha) on Hematological and Biochemical Markers, Hormonal Behavior, and Oxidant Response in Healthy Adults: A Systematic Review Curr. Nutr. Rep., 2023
- Examining the Effects of Herbs on Testosterone Concentrations in Men: A Systematic Review Adv. Nutr., 2021
- Stress and the reproductive axis J. Neuroendocrinol., 2014
- Withania somnifera Chemical Constituents’ in vitro Antioxidant Potential and Their Response on Spermatozoa Parameters Dose Response, 2022
- Role of ashwagandha methanolic extract in the regulation of thyroid profile in hypothyroidism modeled rats Mol. Biol. Rep., 2019
- The Ameliorating Effect of Ashwagandha (Withania somnifera) Extract on Hippocampus and Growth Plate Changes Associated with Propylthiouracil Induced Hypothyroidism in Juvenile Rats: Ashwagandha on Hippocampus and Growth Plate Changes Associated with hypothyroid rats AL-Kindy Coll. Med. J., 2023
- Thyrotoxicosis with Ashwagandha: A Case Report SSRN, 2019
- Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting with Supraventricular Tachycardia Cureus, 2022
- Safety of Ashwagandha Root Extract: A Randomized, Placebo-Controlled, study in Healthy Volunteers Complement. Ther. Med., 2021
- Ashwagandha-induced liver injury-A case series from India and literature review Hepatol. Commun., 2023
- Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial J. Ayurveda Integr. Med., 2020
- Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study Evid. Based Complement. Altern. Med., 2021
- Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing J. Ethnopharmacol., 2021
Used In Evidence Reviews
Similar Papers
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Free radical biology & medicine · 2013
Epidemiology of selenium and type 2 diabetes: can we make sense of it?
Clinical and experimental dermatology · 1989
Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study.
Ophthalmology · 2021
Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
Drugs & aging · 2018